Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - A clinical study using myocardial T1-mapping and extracellular volume quantification by Ntusi, N, Piechnik, S, Francis, J, Ferreira, V, Rai, AB, Matthews, P, Robson, MD, Moon, J, Wordsworth, P, Neubauer, S, Karamitsos, T

Mapping of MHC class II and III genes associated with Ankylosing spondylitis independent of HLA-B27 by Sims, A, Cordell, H, Barnardo, M, Broxholme, S, Herzberg, I, Bradbury, L, Calin, A, Wordsworth, B, Darke, C, Brown, M

Purification and characterization of endogenous peptides extracted from HLA-DR isolated from the spleen of a patient with rheumatoid arthritis. by Gordon, R, Young, J, Rayner, S, Luke, R, Crowther, M, Wordsworth, P, Bell, J, Hassall, G, Evans, J, Hinchliffe, SA

Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial by van der Heijde, D, Luo, M, Matsumoto, A, Mease, P, Torre-Alonso, J, Wordsworth, B, Wong, R, Davis, J

Chromosome conformation capture approaches to investigate 3D genome architecture in Ankylosing Spondylitis by Connor Davidson, Connor Davidson, B. Paul Wordsworth, Carla J. Cohen, Carla J. Cohen, Julian C. Knight, Matteo Vecellio, Matteo Vecellio

Get full text

Adalimumab is effective and well-tolerated in patients with ankylosing spondylitis (AS) in day-to-day clinical practice - Results from rhapsody by Wordsworth, P, Claudepierre, P, Loza, E, Olivieri, I, Keat, A, Mantika, I, Wong, R, Kron, M, Kupper, H, Rudwaleit, M

Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patients by Tsiachristas, A, Vallance, G, Koleva-Kolarova, R, Taylor, H, Solomons, L, Rizzo, G, Chaytor, C, Miah, J, Wordsworth, S, Hassan, AB

The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis. by Brown, M, Rudwaleit, M, Pile, K, Kennedy, L, Shatford, J, Amos, C, Siminovitch, K, Rubin, L, Calin, A, Wordsworth, B

Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. by Harvey, D, Pointon, J, Sleator, C, Meenagh, A, Farrar, C, Sun, J, Senitzer, D, Middleton, D, Brown, M, Wordsworth, B

Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. by Hall, F, Weeks, D, Camilleri, J, Williams, L, Amos, N, Darke, C, Gibson, K, Pile, K, Wordsworth, B, Jessop, J

Preferences for medical consultations from online providers: evidence from a discrete choice experiment in the United Kingdom by Buchanan, J, Roope, L, Morrell, L, Pouwels, K, Robotham, J, Abel, L, Crook, D, Peto, T, Butler, C, Walker, A, Wordsworth, S

BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. by Keat, A, Barkham, N, Bhalla, A, Gaffney, K, Marzo-Ortega, H, Paul, S, Rogers, F, Somerville, M, Sturrock, R, Wordsworth, P

Guidance for the harmonisation and improvement of economic evaluations of personalised medicine by Vellekoop, H, Huygens, S, Versteegh, M, Szilberhorn, L, Zelei, T, Nagy, B, Koleva-Kolarova, R, Tsiachristas, A, Wordsworth, S, Rutten-van Mölken, M

Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. by Sykes, B, Ogilvie, D, Wordsworth, P, Wallis, G, Mathew, C, Beighton, P, Nicholls, A, Pope, F, Thompson, E, Tsipouras, P

GOLIMUMAB IS EFFICACIOUS IN ANTI-TNF EXPERIENCED PTS WITH ACTIVE RA REGARDLESS OF TYPE OF AGENT OR REASON FOR DISCONTINUATION OF PRIOR ANTI-TNF: GO-AFTER STUDY by Smolen, J, Wordsworth, P, Doyle, M, Kay, J, Matteson, E, Landewe, R, Hsia, E, Zhou, Y, Rahman, M, Investigator, G

HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. by Young, R, Dekker, J, Wordsworth, B, Schou, C, Pile, K, Matthiesen, F, Rosenberg, WM, Bell, J, Hopkin, J, Cookson, W

A novel human leucocyte antigen-DRB1 genotyping method based on multiplex primer extension reactions. by Jaakkola, E, Herzberg, I, Crane, A, Pointon, J, Laiho, K, Kauppi, M, Kaarela, K, Wordsworth, B, Tuomilehto, J, Brown, M

Interleukin 23 receptor and susceptibility to ankylosing spondylitis by Pointon, J, Harvey, D, Farrar, C, Bradbury, L, Buckingham, L, Stone, M, Sturrock, R, Brown, M, Wordsworth, P, Tasc, A

A genome-wide screen for susceptibility loci in ankylosing spondylitis. by Brown, M, Pile, K, Kennedy, L, Campbell, D, Andrew, L, March, R, Shatford, J, Weeks, D, Calin, A, Wordsworth, B

Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK by Richard A Anderson, Chiara Bucciarelli-Ducci, John P Greenwood, Barnaby C Reeves, Brett Doble, Sarah Wordsworth, Elizabeth A Stokes, Stephen Dorman

Get full text